Structural formula of Lapatinib
Lapatinib (Lapatinib) is a small molecule drug that is a 4-aniline quinazoline kinase inhibitor. It exists as the xylene sulfonate monohydrate with the chemical name N-(3-chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine bis(4-methylbenzenesulfonate) monohydrate. Its molecular formula is C29H26ClFN4O4S (C7H8O3S)2 H2O, and its molecular weight is 943.5g/mol. Each 250 mg lapatinib tosylate tablet contains 405 mg of lapatinib xylene sulfonate monohydrate, equivalent to 398 mg of lapatinib xylene sulfonate or 250 mg of lapatinib free base.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)